Literature DB >> 20534827

The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat.

David García-Galiano1, Víctor M Navarro, Juan Roa, Francisco Ruiz-Pino, Miguel Angel Sánchez-Garrido, Rafael Pineda, Juan Manuel Castellano, Magdalena Romero, Enrique Aguilar, Francisco Gaytán, Carlos Diéguez, Leonor Pinilla, Manuel Tena-Sempere.   

Abstract

The hypothalamic peptide, nesfatin-1, derived from the precursor NEFA/nucleobindin 2 (NUCB2), was recently identified as anorexigenic signal, acting in a leptin-independent manner. Yet its participation in the regulation of other biological functions gated by body energy status remains unexplored. We show herein that NUCB2/nesfatin-1 is involved in the control of female puberty. NUCB2/nesfatin mRNA and protein were detected at the hypothalamus of pubertal female rats, with prominent signals at lateral hypothalamus (LHA), paraventricular (PVN), and supraoptic (SON) nuclei. Hypothalamic NUCB2 expression raised along pubertal transition, with detectable elevations of its mRNA levels at LHA, PVN, and SON, and threefold increase of its total protein content between late-infantile and peripubertal periods. Conditions of negative energy balance, such as 48 h fasting or sustained subnutrition, decreased hypothalamic NUCB2 mRNA and/or protein levels in pubertal females. At this age, central administration of nesfatin-1 induced modest but significant elevations of circulating gonadotropins, whose magnitude was notably augmented in conditions of food deprivation. Continuous intracerebroventricular infusion of antisense morpholino oligonucleotides (as-MONs) against NUCB2 along pubertal maturation, which markedly reduced hypothalamic NUCB2 protein content, delayed vaginal opening and decreased ovarian weights and serum luteinizing hormone (LH) levels. In contrast, in adult female rats, intracerebroventricular injection of nesfatin did not stimulate LH or follicle-stimulating hormone secretion; neither did central as-MON infusion alter preovulatory gonadotropin surges, despite suppression of hypothalamic NUCB2. In sum, our data are the first to disclose the indispensable role of NUCB2/nesfatin-1 in the central networks driving puberty onset, a function that may contribute to its functional coupling to energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534827      PMCID: PMC6632688          DOI: 10.1523/JNEUROSCI.5828-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

Review 1.  Novel signals for the integration of energy balance and reproduction.

Authors:  R Fernandez-Fernandez; A C Martini; V M Navarro; J M Castellano; C Dieguez; E Aguilar; L Pinilla; M Tena-Sempere
Journal:  Mol Cell Endocrinol       Date:  2006-06-08       Impact factor: 4.102

2.  Keeping the fat off with nesfatin.

Authors:  Martin G Myers
Journal:  Nat Med       Date:  2006-11       Impact factor: 53.440

3.  Less fat with nesfatin.

Authors:  William F Colmers
Journal:  Trends Endocrinol Metab       Date:  2007-03-08       Impact factor: 12.015

4.  Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats.

Authors:  Juan M Castellano; Victor M Navarro; Rafael Fernández-Fernández; Juan Roa; Eva Vigo; Rafael Pineda; Carlos Dieguez; Enrique Aguilar; Leonor Pinilla; Manuel Tena-Sempere
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

5.  Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition.

Authors:  J M Castellano; V M Navarro; R Fernández-Fernández; R Nogueiras; S Tovar; J Roa; M J Vazquez; E Vigo; F F Casanueva; E Aguilar; L Pinilla; C Dieguez; M Tena-Sempere
Journal:  Endocrinology       Date:  2005-06-02       Impact factor: 4.736

6.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

Review 7.  Interacting appetite-regulating pathways in the hypothalamic regulation of body weight.

Authors:  S P Kalra; M G Dube; S Pu; B Xu; T L Horvath; P S Kalra
Journal:  Endocr Rev       Date:  1999-02       Impact factor: 19.871

8.  Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54.

Authors:  V M Navarro; R Fernández-Fernández; J M Castellano; J Roa; A Mayen; M L Barreiro; F Gaytan; E Aguilar; L Pinilla; C Dieguez; M Tena-Sempere
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

9.  Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide.

Authors:  V M Navarro; J M Castellano; R Fernández-Fernández; M L Barreiro; J Roa; J E Sanchez-Criado; E Aguilar; C Dieguez; L Pinilla; M Tena-Sempere
Journal:  Endocrinology       Date:  2004-07-08       Impact factor: 4.736

10.  Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain.

Authors:  G Cristina Brailoiu; Siok L Dun; Eugen Brailoiu; Saadet Inan; Jun Yang; Jaw Kang Chang; Nae J Dun
Journal:  Endocrinology       Date:  2007-07-12       Impact factor: 4.736

View more
  39 in total

1.  Nesfatin-1 and other hormone alterations in polycystic ovary syndrome.

Authors:  Rulin Deniz; Bilgin Gurates; Suleyman Aydin; Husnu Celik; Ibrahim Sahin; Yakup Baykus; Zekiye Catak; Aziz Aksoy; Cihan Citil; Sami Gungor
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

Review 2.  Metabolic influences on neuroendocrine regulation of reproduction.

Authors:  Víctor M Navarro; Ursula B Kaiser
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-08       Impact factor: 3.243

3.  Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.

Authors:  Figen Kir Sahin; Serap Baydur Sahin; Ulku Mete Ural; Medine Cumhur Cure; Senol Senturk; Yesim Bayoglu Tekin; Gulsah Balik; Erkan Cure; Suleyman Yuce; Aynur Kirbas
Journal:  Bosn J Basic Med Sci       Date:  2015-07-09       Impact factor: 3.363

Review 4.  Nesfatin-1 and its effects on different systems.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 5.  Minireview: nesfatin-1--an emerging new player in the brain-gut, endocrine, and metabolic axis.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

6.  Immunohistochemical localization and possible functions of nesfatin-1 in the testis of mice during pubertal development and sexual maturation.

Authors:  Ashutosh Ranjan; Mayank Choubey; Toshihiko Yada; Amitabh Krishna
Journal:  J Mol Histol       Date:  2019-09-20       Impact factor: 2.611

7.  Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.

Authors:  A Stengel; Y Taché
Journal:  Horm Metab Res       Date:  2013-09-18       Impact factor: 2.936

Review 8.  Multi-functional peptide hormone NUCB2/nesfatin-1.

Authors:  Suleyman Aydin
Journal:  Endocrine       Date:  2013-03-23       Impact factor: 3.633

Review 9.  The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.

Authors:  A Stengel; M Mori; Y Taché
Journal:  Obes Rev       Date:  2013-08-27       Impact factor: 9.213

Review 10.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.